Home > Boards > US Listed > Biotechs > Applied DNA Sciences Inc. (APDN)

Why would the company put out news now

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Foose Member Profile
 
Followed By 2
Posts 989
Boards Moderated 1
Alias Born 12/08/16
160x600 placeholder
Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/15/2019 12:08:00 PM
Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/13/2019 9:20:00 AM
Registration of Additional Securities (up to 20%) (s-1mef) Edgar (US Regulatory) - 11/13/2019 9:13:26 AM
Successful DNA Tagging of Leather at One of the World’s Largest Tanneries Business Wire - 11/12/2019 9:03:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 4:17:47 PM
Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors  Business Wire - 11/8/2019 3:22:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/8/2019 3:15:19 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/1/2019 5:22:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 4:07:01 PM
Applied DNA Sciences Announces 1-For-40 Reverse Stock Split Business Wire - 10/31/2019 1:00:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 10/25/2019 4:28:35 PM
Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials Business Wire - 10/22/2019 8:30:00 AM
Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance Business Wire - 10/16/2019 5:30:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/8/2019 4:02:30 PM
Molecular Tagging of Pharmaceutical Excipients Utilizing Applied DNA’s Technology Published in Peer-Reviewed Journal Business Wire - 10/4/2019 5:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 10/3/2019 4:03:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:32:21 AM
Applied DNA Receives Extension from Nasdaq Business Wire - 10/3/2019 5:00:00 AM
LineaRx’s iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over PSA as a Biomarker in Pros... Business Wire - 10/1/2019 8:30:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 9/26/2019 5:23:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/25/2019 4:03:37 PM
Applied DNA Receives $1 Million Order to Supply SigNature® T Molecular Taggant for 2019-2020 Cotton Harvest Season Business Wire - 9/24/2019 9:00:00 AM
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction Business Wire - 9/19/2019 4:00:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 9/18/2019 5:30:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2019 4:02:08 PM
Foose   Saturday, 10/12/19 10:57:07 PM
Re: harerabbit post# 56612
Post # of 56907 
Why would the company put out news now or before RS? The RS gets the stock solves one Nasdaq req. The S1 solves the other. SP won't change outside of a $10 million pharma order or something else with a big dollar number.

IR is playing the PR strategy right. It would be spitting into the wind. Save it for when the wind has died down.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist